https://stockwhiz.ai/news/rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-combination-demons-734a2a15Stockwhizen2026-10-25T13:45:00.035ZRYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancerhttps://stockwhiz.ai/news/arrivent-announces-initial-phase-1-data-for-cdh17-targeted-adc-arr-217-2f28205cStockwhizen2026-10-25T13:00:00.069ZArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026https://stockwhiz.ai/news/amarin-provides-update-on-university-of-leeds-sponsored-phase-3-epa-fo-4644fdc3Stockwhizen2026-10-25T12:11:03.092ZAmarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases (CRCLM)https://stockwhiz.ai/news/agenus-reports-72-of-patients-with-locally-advanced-dmmr-colon-cancer--92e638f7Stockwhizen2026-10-25T11:00:00.157ZAgenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026https://stockwhiz.ai/news/genmab-announces-updated-follow-up-analyses-from-phase-2-study-of-peto-00722a2bStockwhizen2026-10-25T11:00:00.108ZGenmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancerhttps://stockwhiz.ai/news/novabridge-biosciences-reports-mature-phase-1b-data-at-esmo-2026-posit-2100a9fcStockwhizen2026-10-25T10:59:59.983ZNovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Developmenthttps://stockwhiz.ai/news/reg-genmab-announces-updated-follow-up-analyses-from-phase-2-study-of--2af3bbefStockwhizen2026-10-25T10:59:59.925ZREG-Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancerhttps://stockwhiz.ai/news/libtayo-cemiplimab-longer-term-data-show-increasing-and-clinically-mea-1f0ef50bStockwhizen2026-10-25T09:14:59.964ZLibtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)https://stockwhiz.ai/news/xencor-presents-phase-1-dose-selection-data-for-xmab819-a-potential-fi-057f3dfeStockwhizen2026-10-25T08:35:00.091ZXencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumorshttps://stockwhiz.ai/news/johnson-johnson-reports-75-tumor-response-rate-in-advanced-prostate-ca-697e2d28Stockwhizen2026-10-25T07:30:00.225ZJohnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ moleculehttps://stockwhiz.ai/news/new-data-on-lilly-x27-s-investigational-treatment-olomorasib-at-esmo-2-6346b1ffStockwhizen2026-10-25T07:30:00.027ZNew data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancerhttps://stockwhiz.ai/news/biontech-and-bristol-myers-squibb-report-encouraging-global-phase-2-da-1fcc7824Stockwhizen2026-10-25T07:29:59.860ZBioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapyhttps://stockwhiz.ai/news/borr-drilling-limited-prospector-5-rig-incident-5a806164Stockwhizen2026-10-25T06:08:39.160ZBorr Drilling Limited - Prospector 5 Rig Incidenthttps://stockwhiz.ai/news/climb-bio-presents-initial-prismn-phase-2-data-from-budoprutug-in-pmn--1dbd7428Stockwhizen2026-10-24T23:29:59.912ZClimb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026https://stockwhiz.ai/news/axon-announces-body-5-next-generation-camera-built-for-the-ai-era-8e7721baStockwhizen2026-10-24T17:00:00.043ZAxon Announces Body 5: Next-Generation Camera Built for the AI Erahttps://stockwhiz.ai/news/pfizer-x27-s-25-valent-pediatric-pneumococcal-conjugate-vaccine-candid-0fe5872bStockwhizen2026-10-24T15:18:00.145ZPfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026https://stockwhiz.ai/news/from-private-credit-to-fusion-power-new-to-the-street-show-777-premier-c8837552Stockwhizen2026-10-24T14:31:20.370ZFrom Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Televisionhttps://stockwhiz.ai/news/imdelltra-in-combination-with-imfinzi-reduced-risk-of-death-by-an-unpr-1bf87700Stockwhizen2026-10-24T14:30:00.036ZIMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCERhttps://stockwhiz.ai/news/johnson-johnson-announces-erleada-apalutamide-treatment-before-and-aft-94c5dbdaStockwhizen2026-10-24T12:55:08.680ZJohnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancerhttps://stockwhiz.ai/news/parabilis-medicines-presents-updated-phase-1-2-data-for-zolucatetide-d-b2988ad6Stockwhizen2026-10-24T12:44:59.340ZParabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumorshttps://stockwhiz.ai/news/semtech-brings-5g-network-slicing-fips-140-3-to-iacp-2026-c8bc1ea0Stockwhizen2026-10-24T12:00:00.117ZSemtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026https://stockwhiz.ai/news/genmab-and-incyte-announce-clinical-trial-collaboration-in-metastatic--ad70d4c3Stockwhizen2026-10-24T11:01:00.145ZGenmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancerhttps://stockwhiz.ai/news/incyte-and-genmab-announce-clinical-trial-collaboration-in-metastatic--c9f57118Stockwhizen2026-10-24T11:00:00.091ZIncyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancerhttps://stockwhiz.ai/news/reg-genmab-and-incyte-announce-clinical-trial-collaboration-in-metasta-88e1c061Stockwhizen2026-10-24T11:00:00.063ZREG-Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancerhttps://stockwhiz.ai/news/investor-notification-penske-automotive-group-pag-investors-are-remind-a7654352Stockwhizen2026-10-24T09:46:18.869ZInvestor Notification: Penske Automotive Group ($PAG) Investors Are Reminded to Contact BFA Law About the Ongoing Investigation into $212.00 per Share Take-Private Merger Dealhttps://stockwhiz.ai/news/investor-notification-personalis-inc-psnl-investors-are-reminded-to-co-4fa5cc6bStockwhizen2026-10-24T09:46:18.774ZInvestor Notification: Personalis, Inc. ($PSNL) Investors Are Reminded to Contact BFA Law About the Ongoing Investigation into $16.25 per Share Merger Dealhttps://stockwhiz.ai/news/beone-presents-compelling-data-in-hard-to-treat-liver-and-lung-cancers-0bf5ea86Stockwhizen2026-10-24T08:15:00.158ZBeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026https://stockwhiz.ai/news/celcuity-presents-updated-results-from-the-pik3ca-mt-cohort-of-the-pha-90548491Stockwhizen2026-10-24T08:15:00.151ZCelcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026https://stockwhiz.ai/news/compass-therapeutics-announces-publication-of-phase-2-3-companion-002--a94a6836Stockwhizen2026-10-24T08:15:00.116ZCompass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026https://stockwhiz.ai/news/zymeworks-presents-new-phase-1-data-for-folate-receptor-alpha-targetin-d04af20dStockwhizen2026-10-24T06:30:00.121ZZymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026https://stockwhiz.ai/news/immatics-presents-clinical-activity-of-ima402-prame-bispecific-and-ima-1ca7a1fbStockwhizen2026-10-24T06:30:00.065ZImmatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meetinghttps://stockwhiz.ai/news/lilly-presents-first-clinical-data-in-platinum-sensitive-ovarian-cance-9a3afa8dStockwhizen2026-10-24T06:30:00.034ZLilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026https://stockwhiz.ai/news/robot-consulting-announces-receipt-of-nasdaq-delisting-determination-a-dc7d4226Stockwhizen2026-10-24T04:00:01.293ZRobot Consulting Announces Receipt of Nasdaq Delisting Determination and Request to Appeal such Determination Before a Hearings Panelhttps://stockwhiz.ai/news/lunit-and-summit-therapeutics-announce-agreement-to-apply-ai-powered-s-cc93d411Stockwhizen2026-10-24T01:26:44.316ZLunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Developmenthttps://stockwhiz.ai/news/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-r-4a6a0ffeStockwhizen2026-10-24T00:00:00.093ZRxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Ruleshttps://stockwhiz.ai/news/us-metro-bancorp-announces-third-quarter-2026-results-9d47b96bStockwhizen2026-10-23T23:59:00.105ZUS Metro Bancorp Announces Third Quarter 2026 Resultshttps://stockwhiz.ai/news/travere-presents-new-biomarker-data-at-asn-kidney-week-suggesting-fils-1eac16eaStockwhizen2026-10-23T23:20:00.095ZTravere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathyhttps://stockwhiz.ai/news/hawaiian-electric-industries-to-announce-third-quarter-2026-results-no-9ef63f9fStockwhizen2026-10-23T23:16:00.116ZHawaiian Electric Industries to Announce Third Quarter 2026 Results November 6https://stockwhiz.ai/news/club-offers-for-travel-enthusiasts-in-canada-48e4a504Stockwhizen2026-10-23T23:08:29.067ZClub Offers for Travel Enthusiasts in Canadahttps://stockwhiz.ai/news/principal-real-estate-income-fund-announces-changes-in-portfolio-manag-52cddf1fStockwhizen2026-10-23T22:45:00.081ZPrincipal Real Estate Income Fund Announces Changes in Portfolio Managementhttps://stockwhiz.ai/news/black-rock-coffee-bar-continues-expansion-in-california-with-new-ranch-488e25f1Stockwhizen2026-10-23T22:17:23.090ZBlack Rock Coffee Bar Continues Expansion in California with New Rancho Cucamonga Locationhttps://stockwhiz.ai/news/elme-communities-announces-suspended-nyse-trading-anticipates-trading--fd5c4b9fStockwhizen2026-10-23T21:47:00.101ZElme Communities Announces Suspended NYSE Trading; Anticipates Trading Will Begin OTC Effective October 26, 2026https://stockwhiz.ai/news/howard-hughes-holdings-set-to-join-s-p-smallcap-600-3f5137f3Stockwhizen2026-10-23T21:45:48.528ZHoward Hughes Holdings Set to Join S&P SmallCap 600https://stockwhiz.ai/news/blackrock-canada-announces-the-termination-of-ishares-convertible-bond-f303cbc8Stockwhizen2026-10-23T21:23:34.088ZBlackRock® Canada Announces the Termination of iShares Convertible Bond Index ETFhttps://stockwhiz.ai/news/vital-farms-introduces-a-higher-standard-for-free-range-eggs-through-l-53731effStockwhizen2026-10-23T21:05:00.086ZVital Farms Introduces a Higher Standard for Free-Range Eggs Through Limited Pilot at Select Target Retail Storeshttps://stockwhiz.ai/news/notice-to-market-nu-holdings-ltd-60f1b141Stockwhizen2026-10-23T21:03:00.153ZNotice to Market: Nu Holdings Ltd.https://stockwhiz.ai/news/portland-general-electric-declares-dividend-dca33d34Stockwhizen2026-10-23T21:00:11.042ZPortland General Electric Declares Dividendhttps://stockwhiz.ai/news/an2-therapeutics-inc-reports-inducement-grants-under-listing-rule-5635-3257fe79Stockwhizen2026-10-23T21:00:00.098ZAN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)https://stockwhiz.ai/news/the-eastern-company-announces-timing-of-third-quarter-2026-earnings-re-4a63ca4cStockwhizen2026-10-23T20:55:00.529ZThe Eastern Company Announces Timing of Third Quarter 2026 Earnings Release and Conference Callhttps://stockwhiz.ai/news/first-capital-inc-reports-quarterly-earnings-fda2215dStockwhizen2026-10-23T20:45:00.396ZFirst Capital, Inc. Reports Quarterly Earningshttps://stockwhiz.ai/news/myers-industries-announces-quarterly-dividend-d7d506edStockwhizen2026-10-23T20:45:00.086ZMyers Industries Announces Quarterly Dividendhttps://stockwhiz.ai/news/oxford-square-capital-corp-schedules-third-quarter-2026-earnings-relea-b71ccf2cStockwhizen2026-10-23T20:37:45.097ZOxford Square Capital Corp. Schedules Third Quarter 2026 Earnings Release and Conference Call for October 30, 2026https://stockwhiz.ai/news/summit-therapeutics-and-lunit-announce-agreement-to-apply-ai-powered-s-77e16921Stockwhizen2026-10-23T20:37:00.088ZSummit Therapeutics and Lunit Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Developmenthttps://stockwhiz.ai/news/carriage-services-announces-2026-third-quarter-earnings-release-and-co-400fcd65Stockwhizen2026-10-23T20:31:58.086ZCarriage Services Announces 2026 Third Quarter Earnings Release and Conference Call Schedulehttps://stockwhiz.ai/news/energy-services-of-america-completes-famco-acquisition-18f4bec5Stockwhizen2026-10-23T20:30:00.652ZENERGY SERVICES OF AMERICA COMPLETES FAMCO ACQUISITIONhttps://stockwhiz.ai/news/ares-commercial-real-estate-corporation-schedules-earnings-release-and-e7f9738eStockwhizen2026-10-23T20:30:00.451ZAres Commercial Real Estate Corporation Schedules Earnings Release and Conference Call for the Third Quarter Ended September 30, 2026https://stockwhiz.ai/news/amy-johnson-appointed-president-of-gdit-0da6b298Stockwhizen2026-10-23T20:30:00.054ZAmy Johnson Appointed President of GDIThttps://stockwhiz.ai/news/awk-press-release-99cdc272Stockwhizen2026-10-23T20:22:21.563ZAWK press releasehttps://stockwhiz.ai/news/delek-logistics-partners-lp-increases-quarterly-cash-distribution-to-1-afa72576Stockwhizen2026-10-23T20:21:00.080ZDelek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.14 per Common Limited Partner Unithttps://stockwhiz.ai/news/permian-basin-royalty-trust-announces-record-date-and-meeting-date-for-79d0e9fdStockwhizen2026-10-23T20:20:00.027ZPERMIAN BASIN ROYALTY TRUST ANNOUNCES RECORD DATE AND MEETING DATE FOR SPECIAL MEETING TO CONSIDER SOFTVEST PROPOSALShttps://stockwhiz.ai/news/aberdeen-multi-market-income-fund-mmt-announces-upcoming-1-for-4-rever-2c85c2bcStockwhizen2026-10-23T20:17:00.402ZAberdeen Multi-Market Income Fund (MMT) Announces Upcoming 1-for-4 Reverse Stock Splithttps://stockwhiz.ai/news/civista-bancshares-inc-appoints-jeremy-normington-slay-to-board-of-dir-2a15e659Stockwhizen2026-10-23T20:15:00.610ZCivista Bancshares, Inc. Appoints Jeremy Normington-Slay to Board of Directorshttps://stockwhiz.ai/news/nektar-therapeutics-reports-inducement-grants-under-nasdaq-listing-rul-3856c0a3Stockwhizen2026-10-23T20:15:00.411ZNektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)https://stockwhiz.ai/news/hyperliquid-strategies-inc-announces-increase-of-stock-repurchase-prog-a9a9023eStockwhizen2026-10-23T20:15:00.211ZHyperliquid Strategies Inc Announces Increase of Stock Repurchase Program to $100 Millionhttps://stockwhiz.ai/news/fico-holds-mortgage-score-pricing-at-10-for-lenders-enrolled-in-prefer-16c64ed5Stockwhizen2026-10-23T20:15:00.139ZFICO Holds Mortgage Score Pricing at $10 for Lenders Enrolled in Preferred Programhttps://stockwhiz.ai/news/j-star-holding-co-ltd-files-interim-financial-report-on-form-6-k-48112229Stockwhizen2026-10-23T20:15:00.130ZJ-Star Holding Co., Ltd. Files Interim Financial Report on Form 6-Khttps://stockwhiz.ai/news/nike-inc-announces-2026-investor-day-webcast-1d7fef41Stockwhizen2026-10-23T20:15:00.088ZNIKE, Inc. Announces 2026 Investor Day Webcasthttps://stockwhiz.ai/news/mf-international-to-wind-down-legacy-financial-trading-business-shift--16d34f44Stockwhizen2026-10-23T20:15:00.010ZmF International to Wind Down Legacy Financial Trading Business, Shift Focus Completely to Digital Asset Strategyhttps://stockwhiz.ai/news/mueller-water-products-announces-dates-for-fourth-quarter-and-full-yea-ed0b70c3Stockwhizen2026-10-23T20:12:01.098ZMueller Water Products Announces Dates for Fourth Quarter and Full Year 2026 Earnings Release and Conference Callhttps://stockwhiz.ai/news/arbor-realty-trust-schedules-third-quarter-2026-earnings-conference-ca-e4c2c7dfStockwhizen2026-10-23T20:10:00.111ZArbor Realty Trust Schedules Third Quarter 2026 Earnings Conference Callhttps://stockwhiz.ai/news/3-e-network-technology-group-limited-announces-2-for-1-share-consolida-5fda1301Stockwhizen2026-10-23T20:10:00.093Z3 E Network Technology Group Limited Announces 2 for 1 Share Consolidationhttps://stockwhiz.ai/news/surf-air-mobility-to-announce-third-quarter-2026-financial-results-on--07fcfd6eStockwhizen2026-10-23T20:10:00.087ZSurf Air Mobility to Announce Third Quarter 2026 Financial Results on November 5, 2026https://stockwhiz.ai/news/cedar-realty-trust-declares-dividends-on-preferred-stock-84f133c3Stockwhizen2026-10-23T20:05:01.021ZCedar Realty Trust Declares Dividends on Preferred Stockhttps://stockwhiz.ai/news/river-city-bank-reports-third-quarter-2026-results-and-announces-a-qua-2f3f9482Stockwhizen2026-10-23T20:05:00.585ZRiver City Bank Reports Third Quarter 2026 Results and Announces a Quarterly Cash Dividendhttps://stockwhiz.ai/news/cumberland-pharmaceuticals-announces-assist-ssc-trial-top-line-results-17155bc9Stockwhizen2026-10-23T20:05:00.417ZCumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Resultshttps://stockwhiz.ai/news/amtd-digital-s-total-assets-expand-to-us-1-2-billion-with-net-assets-a-b976ac15Stockwhizen2026-10-23T20:05:00.268ZAMTD Digital’s Total Assets Expand to US$1.2 Billion with Net Assets at US$630.6 Million, Maintaining Robust Profitability of US$42.4 Millionhttps://stockwhiz.ai/news/strata-critical-medical-schedules-third-quarter-2026-earnings-conferen-1b757009Stockwhizen2026-10-23T20:05:00.202ZStrata Critical Medical Schedules Third Quarter 2026 Earnings Conference Callhttps://stockwhiz.ai/news/logitech-launches-chain-reaction-to-accelerate-supply-chain-decarboniz-c3455c9cStockwhizen2026-10-23T20:05:00.181ZLogitech Launches ‘Chain Reaction’ to Accelerate Supply Chain Decarbonization towards 2030 Climate Goalshttps://stockwhiz.ai/news/stockholders-of-southern-realty-trust-a-tannenbaum-capital-group-affil-f599582cStockwhizen2026-10-23T20:05:00.173ZStockholders of Southern Realty Trust, a Tannenbaum Capital Group Affiliate, Approve Merger with Sunrise Realty Trust; Company Declares Stub Period Dividendhttps://stockwhiz.ai/news/genedx-to-report-third-quarter-2026-financial-results-on-monday-novemb-974d68cfStockwhizen2026-10-23T20:05:00.134ZGeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026https://stockwhiz.ai/news/middlesex-water-company-increases-common-dividend-by-5-56-67f50d72Stockwhizen2026-10-23T20:05:00.128ZMiddlesex Water Company Increases Common Dividend by 5.56%https://stockwhiz.ai/news/stockholders-of-sunrise-realty-trust-a-tannenbaum-capital-group-affili-2ecc36ceStockwhizen2026-10-23T20:05:00.105ZStockholders of Sunrise Realty Trust, a Tannenbaum Capital Group Affiliate, Approve Merger-Related Proposal with Southern Realty Trust; Company Declares Stub Period Dividendhttps://stockwhiz.ai/news/peoples-financial-services-corp-declares-fourth-quarter-2026-dividend-e778ef75Stockwhizen2026-10-23T20:05:00.094ZPEOPLES FINANCIAL SERVICES CORP. Declares Fourth Quarter 2026 Dividendhttps://stockwhiz.ai/news/stem-announces-notification-of-noncompliance-with-nyse-continued-listi-de29f324Stockwhizen2026-10-23T20:03:00.088ZStem Announces Notification of Noncompliance with NYSE Continued Listing Standardshttps://stockwhiz.ai/news/silvercrest-asset-management-samg-to-announce-third-quarter-2026-resul-cb6a7920Stockwhizen2026-10-23T20:01:00.170ZSilvercrest Asset Management (SAMG) to Announce Third Quarter 2026 Results and Host Investor Conference Callhttps://stockwhiz.ai/news/ardelyx-presents-real-world-data-at-asn-kidney-week-2026-showing-serum-3fd9a7b2Stockwhizen2026-10-23T20:01:00.155ZArdelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Bindershttps://stockwhiz.ai/news/climb-bio-and-mabworks-announce-clym116-mil116-data-demonstrating-deep-1180da65Stockwhizen2026-10-23T20:01:00.135ZClimb Bio and Mabworks Announce CLYM116/MIL116 Data Demonstrating Deep, Durable APRIL Suppression and ~70% Gd-IgA1 Reduction at ASN Kidney Week 2026https://stockwhiz.ai/news/the-ensign-group-schedules-third-quarter-2026-earnings-call-for-wednes-6a459d54Stockwhizen2026-10-23T20:01:00.117ZThe Ensign Group Schedules Third Quarter 2026 Earnings Call for Wednesday, October 28, 2026https://stockwhiz.ai/news/astec-industries-inc-announces-the-company-s-third-quarter-2026-confer-c51a436bStockwhizen2026-10-23T20:01:00.099ZAstec Industries, Inc. Announces the Company’s Third Quarter 2026 Conference Call on November 5, 2026, at 9:00 A.M. Eastern Timehttps://stockwhiz.ai/news/metrocity-bankshares-inc-reports-earnings-for-third-quarter-2026-43542c3aStockwhizen2026-10-23T20:00:01.367ZMETROCITY BANKSHARES, INC. REPORTS EARNINGS FOR THIRD QUARTER 2026https://stockwhiz.ai/news/salesforce-grants-equity-awards-to-m3ter-and-fin-under-its-inducement--62a63e53Stockwhizen2026-10-23T20:00:00.214ZSalesforce Grants Equity Awards to m3ter and Fin Under Its Inducement Equity Incentive Planhttps://stockwhiz.ai/news/orthofix-to-report-third-quarter-2026-financial-results-b4a17816Stockwhizen2026-10-23T20:00:00.131ZOrthofix to Report Third Quarter 2026 Financial Resultshttps://stockwhiz.ai/news/arrivent-to-present-initial-phase-1-data-for-cdh17-targeted-adc-arr-21-6a6d5747Stockwhizen2026-10-23T20:00:00.104ZArriVent to Present Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at the ESMO Congress 2026https://stockwhiz.ai/news/apex-closes-offering-and-completes-nasdaq-listing-ea41018dStockwhizen2026-10-23T19:55:00.765ZApex Closes Offering and Completes NASDAQ Listinghttps://stockwhiz.ai/news/u-s-fda-approves-subcutaneous-induction-regimen-for-abbvie-x27-s-skyri-597c5d4cStockwhizen2026-10-23T19:33:57.837ZU.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn's Diseasehttps://stockwhiz.ai/news/medline-hosts-fourth-annual-medtrans-rodeo-in-mundelein-ill-6d9cb3beStockwhizen2026-10-23T19:15:19.360ZMedline hosts fourth annual MedTrans Rodeo in Mundelein, Ill.https://stockwhiz.ai/news/century-aluminum-sets-date-for-third-quarter-2026-earnings-announcemen-51de197eStockwhizen2026-10-23T19:14:31.095ZCentury Aluminum Sets Date for Third Quarter 2026 Earnings Announcementhttps://stockwhiz.ai/news/key-tronic-corporation-announces-first-quarter-reporting-date-a1ed5f10Stockwhizen2026-10-23T19:08:25.094ZKey Tronic Corporation Announces First Quarter Reporting Datehttps://stockwhiz.ai/news/eon-resources-inc-announces-2nd-quarter-2026-earnings-call-to-be-held--31fe4f1bStockwhizen2026-10-23T19:05:02.953ZEON Resources Inc. Announces 2nd Quarter 2026 Earnings Call to be held Wednesday, October 28, 2026https://stockwhiz.ai/news/hyperliquid-strategies-inc-announces-webcast-to-discuss-results-for-th-73dcc341Stockwhizen2026-10-23T19:00:00.409ZHyperliquid Strategies Inc Announces Webcast to Discuss Results for the Quarter Ended September 30, 2026https://stockwhiz.ai/news/on-crowns-team-grass-league-champions-at-inaugural-on-vitational-golf--cc6778e1Stockwhizen2026-10-23T18:48:00.156Zon!® Crowns Team Grass League Champions at Inaugural on!vitational™ Golf Tournamenthttps://stockwhiz.ai/news/pennymac-mortgage-investment-trust-reschedules-third-quarter-2026-earn-91bb8a30Stockwhizen2026-10-23T17:49:00.082ZPennyMac Mortgage Investment Trust Reschedules Third Quarter 2026 Earnings Call to 6:30 PM ET on Thursday, October 29https://stockwhiz.ai/news/phase-3-rainier-results-supporting-best-in-class-potential-of-povetaci-448c280fStockwhizen2026-10-23T17:42:00.219ZPhase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026https://stockwhiz.ai/news/pennymac-financial-services-inc-reschedules-third-quarter-2026-earning-17e92ea4Stockwhizen2026-10-23T17:42:00.084ZPennyMac Financial Services, Inc. Reschedules Third Quarter 2026 Earnings Call to 5:30 PM ET on Thursday, October 29https://stockwhiz.ai/news/ionis-partner-roche-announces-new-phase-3-data-showing-sefaxersen-sign-de764acbStockwhizen2026-10-23T17:37:00.087ZIonis partner Roche announces new Phase 3 data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)https://stockwhiz.ai/news/macy-s-inc-board-of-directors-declares-quarterly-dividend-69439536Stockwhizen2026-10-23T17:30:00.136ZMacy’s, Inc. Board of Directors Declares Quarterly Dividendhttps://stockwhiz.ai/news/lyntris-schedules-third-quarter-fiscal-year-2026-earnings-release-conf-7162a7ccStockwhizen2026-10-23T17:14:00.081ZLyntris Schedules Third Quarter Fiscal Year 2026 Earnings Release, Conference Call, and Webcasthttps://stockwhiz.ai/news/neonc-breaks-through-key-levels-as-brain-cancer-stock-s-catalysts-cont-e8ff99b6Stockwhizen2026-10-23T17:01:32.098ZNeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continuehttps://stockwhiz.ai/news/telesat-schedules-third-quarter-2026-earnings-conference-call-for-octo-eff2a69eStockwhizen2026-10-23T17:00:00.101ZTelesat schedules third quarter 2026 earnings conference call for October 29, 2026https://stockwhiz.ai/news/popular-inc-declares-a-cash-dividend-of-0-90-per-common-share-5c1a7c59Stockwhizen2026-10-23T16:45:00.094ZPopular, Inc. Declares a Cash Dividend of $0.90 per Common Sharehttps://stockwhiz.ai/news/sigma-lithium-extends-4-year-us-100-million-senior-secured-debt-to-jun-1850f65eStockwhizen2026-10-23T16:26:19.523ZSigma Lithium Extends 4-Year US$100 Million Senior Secured Debt to June 2027; 7,090t Produced Since Restarthttps://stockwhiz.ai/news/nasdaq-confirms-yimutian-s-return-to-compliance-e359f75dStockwhizen2026-10-23T16:15:20.096ZNasdaq Confirms Yimutian’s Return to Compliancehttps://stockwhiz.ai/news/green-plains-to-host-third-quarter-2026-earnings-conference-call-on-no-720f7ef0Stockwhizen2026-10-23T16:00:00.169ZGreen Plains to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026https://stockwhiz.ai/news/verisk-comments-on-delaware-supreme-court-order-regarding-acculynx-759384b3Stockwhizen2026-10-23T16:00:00.164ZVerisk Comments on Delaware Supreme Court Order Regarding AccuLynxhttps://stockwhiz.ai/news/hubbell-incorporated-declares-a-7-dividend-increase-fb510efeStockwhizen2026-10-23T16:00:00.144ZHubbell Incorporated Declares a 7% Dividend Increasehttps://stockwhiz.ai/news/genmab-announces-rinatabart-sesutecan-rina-s-demonstrates-statisticall-836f0d33Stockwhizen2026-10-23T15:55:00.404ZGenmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancerhttps://stockwhiz.ai/news/reg-genmab-announces-rinatabart-sesutecan-rina-s-demonstrates-statisti-5ac9ccccStockwhizen2026-10-23T15:55:00.069ZREG-Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancerhttps://stockwhiz.ai/news/hammond-power-solutions-announces-third-quarter-2026-financial-results-c9eaf47fStockwhizen2026-10-23T15:49:46.099ZHammond Power Solutions Announces Third Quarter 2026 Financial Results Conference Call and Webcast Notificationhttps://stockwhiz.ai/news/reg-compagnie-de-l-x27-odet-financial-information-for-the-third-quarte-d02566c1Stockwhizen2026-10-23T15:45:00.104ZREG-Compagnie de l'Odet : Financial information for the third quarter of 2026https://stockwhiz.ai/news/reg-bollor-financial-information-for-the-third-quarter-of-2026-9562ac63Stockwhizen2026-10-23T15:40:00.083ZREG-Bolloré : Financial information for the third quarter of 2026https://stockwhiz.ai/news/western-alliance-100-brings-business-leaders-together-to-build-connect-8960f996Stockwhizen2026-10-23T15:37:00.084ZWestern Alliance 100 Brings Business Leaders Together to Build Connections, Broaden Perspectives and Advance Growthhttps://stockwhiz.ai/news/worthington-steel-confirms-its-kloeckner-strategy-following-shareholde-0dd77b25Stockwhizen2026-10-23T15:35:00.091ZWorthington Steel Confirms Its Kloeckner Strategy Following Shareholder Votehttps://stockwhiz.ai/news/club-offers-for-travel-enthusiasts-in-germany-7d9a9dc9Stockwhizen2026-10-23T15:26:13.920ZClub Offers for Travel Enthusiasts in Germanyhttps://stockwhiz.ai/news/lkq-investigation-lkq-corp-investors-with-losses-should-contact-block--6f6ece39Stockwhizen2026-10-23T15:07:43.108ZLKQ INVESTIGATION: LKQ Corp. Investors with Losses Should Contact Block & Leviton LLPhttps://stockwhiz.ai/news/drone-nerds-introduces-abz-innovation-c30-high-pressure-cleaning-drone-9d34be82Stockwhizen2026-10-23T15:00:01.013ZDrone Nerds Introduces ABZ Innovation C30 High-Pressure Cleaning Drone to Enterprise Portfoliohttps://stockwhiz.ai/news/youcam-integrates-newly-released-kling-4-0-api-to-turn-photos-into-30--8ff06b78Stockwhizen2026-10-23T15:00:00.300ZYouCam Integrates Newly Released Kling 4.0 API to Turn Photos into 30-Second Stories with Dialogue and Soundhttps://stockwhiz.ai/news/fs-bancorp-inc-announces-the-appointment-of-matthew-d-mullet-as-a-dire-b758a32eStockwhizen2026-10-23T15:00:00.149ZFS Bancorp, Inc. Announces the Appointment of Matthew D. Mullet as a Director of FS Bancorp, Inc.https://stockwhiz.ai/news/tg-therapeutics-announces-phase-1-data-evaluating-azer-cel-in-progress-b47e4edbStockwhizen2026-10-23T14:55:00.090ZTG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026https://stockwhiz.ai/news/2026-sands-shopping-carnival-attracts-nearly-160-000-visitors-over-fou-9a22de50Stockwhizen2026-10-23T14:35:00.245Z2026 Sands Shopping Carnival Attracts Nearly 160,000 Visitors Over Four Days To Support Macao Businesseshttps://stockwhiz.ai/news/philip-morris-international-reports-2026-third-quarter-first-nine-mont-5e6f2934Stockwhizen2026-10-23T14:34:46.495ZPhilip Morris International Reports 2026 Third-Quarter & First Nine-Months Results and Updates 2026 Full-Year Adjusted Diluted EPS Forecast for Currency Onlyhttps://stockwhiz.ai/news/your-holiday-business-is-live-how-do-you-get-customers-f93ac595Stockwhizen2026-10-23T14:30:00.881ZYour Holiday Business Is Live. How Do You Get Customershttps://stockwhiz.ai/news/bristol-myers-squibb-presents-results-from-phase-1-breakfree-2-study-o-0200b831Stockwhizen2026-10-23T14:30:00.129ZBristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSToronto 2026https://stockwhiz.ai/news/kyverna-therapeutics-highlights-promising-updated-clinical-data-with-m-25d58dc6Stockwhizen2026-10-23T14:30:00.102ZKyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026https://stockwhiz.ai/news/cts-corporation-announces-completion-of-the-acquisition-of-millar-hold-9b0c7e9cStockwhizen2026-10-23T14:28:54.090ZCTS Corporation Announces Completion of the Acquisition of Millar Holdingshttps://stockwhiz.ai/news/reg-millennium-partners-l-p-form-8-3-afbc0ac5Stockwhizen2026-10-23T14:25:00.471ZREG-Millennium Partners, L.P. Form 8.3https://stockwhiz.ai/news/travelzoo-q3-2026-earnings-conference-call-on-october-27-at-11-00-am-e-c585c7daStockwhizen2026-10-23T14:16:17.168ZTravelzoo Q3 2026 Earnings Conference Call on October 27 at 11:00 AM EThttps://stockwhiz.ai/news/ziihera-zanidatamab-hrii-combinations-demonstrate-sustained-survival-a-4500237eStockwhizen2026-10-23T14:15:00.218ZZiihera® (zanidatamab-hrii) Combinations Demonstrate Sustained Survival at Three Years in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma at ESMO 2026https://stockwhiz.ai/news/zentalis-pharmaceuticals-announces-meaningful-median-overall-survival--bd8cccb8Stockwhizen2026-10-23T14:15:00.143ZZentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026https://stockwhiz.ai/news/iovance-presents-new-data-at-esmo-2026-demonstrating-deep-durable-resp-9616cd7bStockwhizen2026-10-23T14:15:00.118ZIovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanomahttps://stockwhiz.ai/news/beone-medicines-reports-sustained-survival-benefit-with-tevimbra-ziihe-41db3f71Stockwhizen2026-10-23T14:15:00.087ZBeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancerhttps://stockwhiz.ai/news/lifezone-metals-confirms-advanced-negotiations-with-orion-cmc-on-kaban-f309e1aaStockwhizen2026-10-23T14:10:00.096ZLifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Projecthttps://stockwhiz.ai/news/the-18th-skechers-pier-to-pier-friendship-walk-raises-3-3-million-for--0be05f28Stockwhizen2026-10-23T14:07:00.085ZThe 18th Skechers Pier to Pier Friendship Walk Raises $3.3 Million for Kidshttps://stockwhiz.ai/news/polaris-expands-call-of-duty-collaboration-as-polaris-dagor-joins-mode-1095d9e5Stockwhizen2026-10-23T14:05:00.013ZPolaris Expands Call of Duty® Collaboration as Polaris DAGOR Joins Modern Warfare® 4https://stockwhiz.ai/news/north-dallas-bank-trust-co-announces-third-quarter-earnings-0835951bStockwhizen2026-10-23T14:03:00.148ZNorth Dallas Bank & Trust Co. Announces Third Quarter Earningshttps://stockwhiz.ai/news/duluth-trading-named-official-rugged-lifestyle-partner-of-sporting-kan-59119520Stockwhizen2026-10-23T14:00:03.664ZDuluth Trading Named Official Rugged Lifestyle Partner of Sporting Kansas Cityhttps://stockwhiz.ai/news/leggett-dynamics-x27-s-mid-class-massage-system-wins-gasgoo-x27-s-best-0905c014Stockwhizen2026-10-23T14:00:02.471ZLeggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Awardhttps://stockwhiz.ai/news/e-power-s-mid-sulfur-coke-anode-route-achieves-3-2-higher-specific-cap-e05220d9Stockwhizen2026-10-23T14:00:00.229ZE-Power’s Mid-Sulfur Coke Anode Route Achieves 3.2% Higher Specific Capacity Than Conventional Low-Sulfur Cokehttps://stockwhiz.ai/news/eddie-bauer-adventure-club-expands-to-texas-hill-country-with-first-ou-9d5338c3Stockwhizen2026-10-23T14:00:00.145ZEddie Bauer Adventure Club Expands to Texas Hill Country with First Outposthttps://stockwhiz.ai/analyst-ratings/reddit-inc-wedbush-buy-pt-221-b9383b23Stockwhizen2026-10-23T13:57:12.966ZWedbush maintains Buy on Reddit, maintains PT at $221https://stockwhiz.ai/analyst-ratings/micron-technology-inc-wedbush-buy-pt-1400-8ce02966Stockwhizen2026-10-23T13:56:21.628ZWedbush maintains Buy on Micron Technology, maintains PT at $1400https://stockwhiz.ai/analyst-ratings/datadog-inc-bofa-securities-buy-pt-335-9180ee95Stockwhizen2026-10-23T13:55:44.602ZBofA Securities maintains Buy on Datadog, raises PT to $335 from $305https://stockwhiz.ai/analyst-ratings/ast-spacemobile-inc-scotiabank-sector-outperform-pt-55-7-36c3b040Stockwhizen2026-10-23T13:54:27.727ZScotiabank upgrades AST SpaceMobile to Sector Outperform from Sector Perform; price target $55.70